FR2887884B1 - Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique - Google Patents

Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique

Info

Publication number
FR2887884B1
FR2887884B1 FR0506672A FR0506672A FR2887884B1 FR 2887884 B1 FR2887884 B1 FR 2887884B1 FR 0506672 A FR0506672 A FR 0506672A FR 0506672 A FR0506672 A FR 0506672A FR 2887884 B1 FR2887884 B1 FR 2887884B1
Authority
FR
France
Prior art keywords
biotechnological
epitopes
treatment
medical applications
chronic hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0506672A
Other languages
English (en)
Other versions
FR2887884A1 (fr
Inventor
Marie Louise Michel
Bourgine Mayline Mancini
Florence Bayard
Patrick Soussan
Dina Kremsdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR0506672A priority Critical patent/FR2887884B1/fr
Priority to PCT/FR2006/001532 priority patent/WO2007003775A1/fr
Publication of FR2887884A1 publication Critical patent/FR2887884A1/fr
Application granted granted Critical
Publication of FR2887884B1 publication Critical patent/FR2887884B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
FR0506672A 2005-06-29 2005-06-29 Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique Expired - Fee Related FR2887884B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0506672A FR2887884B1 (fr) 2005-06-29 2005-06-29 Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique
PCT/FR2006/001532 WO2007003775A1 (fr) 2005-06-29 2006-06-29 Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0506672A FR2887884B1 (fr) 2005-06-29 2005-06-29 Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique

Publications (2)

Publication Number Publication Date
FR2887884A1 FR2887884A1 (fr) 2007-01-05
FR2887884B1 true FR2887884B1 (fr) 2007-09-14

Family

ID=35744580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0506672A Expired - Fee Related FR2887884B1 (fr) 2005-06-29 2005-06-29 Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique

Country Status (2)

Country Link
FR (1) FR2887884B1 (fr)
WO (1) WO2007003775A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466869T1 (de) * 1993-03-05 2010-05-15 Epimmune Inc Verfahren zur herstellung von immunogenen hla- a2.1-bindenden peptiden

Also Published As

Publication number Publication date
WO2007003775A1 (fr) 2007-01-11
FR2887884A1 (fr) 2007-01-05

Similar Documents

Publication Publication Date Title
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
EP1745808A4 (fr) Matiere filtrante a usage medical et colonne de circulation et filtre sanguin extracorporels l'utilisant
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
EA201000424A1 (ru) Антитела к il-23
DK1286711T3 (da) Infusion af væsker i menneske- eller dyrelegemer
WO2007038459A3 (fr) Composes de carboxyamine et leurs methodes d'utilisation
CY1107609T1 (el) Απεικoνιση, διaγνωση και θεραπεiα ασθeνειας
AP2081A (en) Oligomeric peptides and their use for the treatment of HIV infections
HK1213782A1 (zh) 在診斷和治療類風濕性關節炎中使用的包含抗- 單克隆抗體的藥物組合物
DK1750713T3 (da) Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner
DK1411064T3 (da) Gangliosid-associerede rekombinante antistoffer og anvendelsen deraf i diagnosen og behandlingen af tumorer
CL2007003332A1 (es) Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
WO2013148686A3 (fr) Formulations stables d'agent de liaison à igg4
FR2886850B1 (fr) Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
FR2883181B1 (fr) Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
FR2886852B1 (fr) Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
SI1912513T1 (sl) Nove mlečne proteinske frakcije in njihova uporaba za preprečevanje ali zdravljenje kroničnih vnetnih bolezni
FR2924712B1 (fr) Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
FR2887884B1 (fr) Epitopes de la proteine hbsp et leurs applications biotechnologiques et medicales, notamment pour le traitement de l'hepatite b chronique
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
FR2906469B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme
PL376122A1 (pl) Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki
FR2903998B1 (fr) Modulateurs de elovl5 dans le traitement de l'acne ou de l'hyperseborrhee
FR2857014B1 (fr) Peptides chelatant l'uranium et leurs applications

Legal Events

Date Code Title Description
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20140228